AXN Research

5-AMINO-1MQ emerged in preclinical research as an investigational NNMT (Nicotinamide N-Methyltransferase) inhibitor studied for its potential role in metabolic regulation and cellular energy balance. Scientific interest increased due to observed interactions with NAD+ related pathways, mitochondrial activity, and experimental metabolic models. Research surrounding NNMT inhibition continues to expand within the fields of metabolism, cellular signaling, and experimental longevity science.

5-AMINO-1MQ has been investigated for its inhibitory action on NNMT, an enzyme involved in nicotinamide metabolism and methyl donor utilization.

Experimental studies suggest that NNMT inhibition may influence:

- NAD+ salvage pathways
- Cellular energy metabolism
- Glucose and lipid handling
- Mitochondrial activity
- Epigenetic and methylation-related processes

Preclinical models have also explored its potential relationship with metabolic regulation and body composition pathways.

In vitro and preclinical studies have evaluated the effects of 5-AMINO-1MQ on enzymatic activity, cellular metabolism, and experimental metabolic models.

Research investigations have reported:

- Modulation of metabolic biomarkers
- Changes in adiposity-related parameters
- Effects on glucose metabolism in experimental models
- Potential influence on inflammatory signaling pathways

Current data remains primarily preclinical, and comprehensive human safety and efficacy studies are still limited.

Selected preclinical literature involving NNMT inhibition, metabolic regulation, intracellular signaling, NAD+ related pathways, and experimental cellular studies associated with 5-AMINO-1MQ.

The requested resource cannot be located on the AXN Research website at this time.

Our cross-referencing and indexing procedures indicate that the content is not presently available within the site’s accessible records, archives, or indexed materials. This may occur for several reasons, including but not limited to: (a) temporary or permanent depublication; (b) permanent deletion; (c) removal pursuant to a formal takedown request, legal notice, compliance action, or policy enforcement measure; or (d) the possibility that the referenced content was never published, archived, indexed, or otherwise made available on the AXN Research website or its associated services.

In certain circumstances, references to unavailable resources may originate from outdated links, third-party citations, user-generated references, automated indexing systems, incomplete archival records, typographical errors, or materials that were proposed, drafted, or referenced externally without ever being formally published by AXN Research. Accordingly, the absence of a resource should not be interpreted as confirmation that such material previously existed on the platform.

AXN Research maintains procedures for evaluating lawful requests, investigating claims regarding unavailable or disputed content, and responding to allegations of improper removal, unauthorized publication, or rights violations. The organization reserves the right to restrict, remove, preserve, decline to disclose, or otherwise manage content and related records at its sole discretion where necessary to comply with legal obligations, enforce platform rules, protect users, preserve system integrity, mitigate liability, or safeguard operational and security interests.

5-AMINO-1MQ (50mg) Capsules

Historical Development

Receptor Mechanisms and Intracellular Signaling

Scientific Research and Studies

References

THE FOUNDATION OF MODERN PEPTIDE RESEARCH

PREMIUM HYPER PEPTIDES

WORLDWIDE LOGISTICS

SCIENTIFIC DEVELOPMENT